Triglav Skladi D.O.O. Takes Position in The Cigna Group (NYSE:CI)

Triglav Skladi D.O.O. bought a new position in shares of The Cigna Group (NYSE:CI - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor bought 29,537 shares of the health services provider's stock, valued at approximately $8,156,000.

Other large investors also recently modified their holdings of the company. TCTC Holdings LLC acquired a new stake in shares of The Cigna Group during the 4th quarter worth $25,000. Collier Financial acquired a new stake in The Cigna Group in the fourth quarter valued at about $32,000. Compagnie Lombard Odier SCmA acquired a new stake in The Cigna Group in the fourth quarter valued at about $37,000. Transce3nd LLC acquired a new stake in The Cigna Group in the fourth quarter valued at about $38,000. Finally, Heck Capital Advisors LLC acquired a new stake in The Cigna Group in the fourth quarter valued at about $53,000. 86.99% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several analysts recently weighed in on the company. Oppenheimer reduced their price objective on The Cigna Group from $400.00 to $375.00 and set an "outperform" rating on the stock in a research note on Friday, January 31st. Stephens reduced their price objective on The Cigna Group from $410.00 to $380.00 and set an "overweight" rating on the stock in a research note on Friday, January 31st. Sanford C. Bernstein lowered The Cigna Group from an "outperform" rating to a "market perform" rating and set a $323.00 price objective on the stock. in a research note on Thursday, February 6th. Royal Bank of Canada set a $355.00 price objective on The Cigna Group in a research note on Friday, January 31st. Finally, Mizuho raised their price objective on The Cigna Group from $360.00 to $384.00 and gave the company an "outperform" rating in a research note on Wednesday, April 9th. Two investment analysts have rated the stock with a hold rating, sixteen have issued a buy rating and three have assigned a strong buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of "Buy" and a consensus target price of $379.33.

The Cigna Group Trading Up 1.2%

Shares of The Cigna Group stock traded up $3.68 during midday trading on Friday, reaching $316.36. The company had a trading volume of 1,667,838 shares, compared to its average volume of 1,714,787. The stock has a fifty day moving average price of $325.35 and a 200 day moving average price of $310.06. The company has a debt-to-equity ratio of 0.70, a current ratio of 0.66 and a quick ratio of 0.72. The firm has a market cap of $84.51 billion, a PE ratio of 25.85, a P/E/G ratio of 0.98 and a beta of 0.47. The Cigna Group has a fifty-two week low of $262.03 and a fifty-two week high of $370.83.

The Cigna Group (NYSE:CI - Get Free Report) last posted its quarterly earnings data on Friday, May 2nd. The health services provider reported $6.74 EPS for the quarter, topping analysts' consensus estimates of $6.35 by $0.39. The company had revenue of $65.45 billion for the quarter, compared to analyst estimates of $60.39 billion. The Cigna Group had a return on equity of 18.61% and a net margin of 1.39%. The firm's quarterly revenue was up 14.4% on a year-over-year basis. During the same period in the previous year, the firm earned $6.47 earnings per share. On average, equities analysts anticipate that The Cigna Group will post 29.77 earnings per share for the current year.

The Cigna Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, June 18th. Investors of record on Tuesday, June 3rd will be paid a $1.51 dividend. This represents a $6.04 dividend on an annualized basis and a dividend yield of 1.91%. The ex-dividend date of this dividend is Tuesday, June 3rd. The Cigna Group's dividend payout ratio is currently 33.44%.

Insiders Place Their Bets

In other news, insider Noelle K. Eder sold 9,944 shares of the stock in a transaction dated Friday, March 7th. The shares were sold at an average price of $320.00, for a total transaction of $3,182,080.00. Following the transaction, the insider now owns 13,406 shares of the company's stock, valued at $4,289,920. This represents a 42.59% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CEO David Cordani sold 26,527 shares of the stock in a transaction dated Monday, March 3rd. The stock was sold at an average price of $308.12, for a total transaction of $8,173,499.24. Following the transaction, the chief executive officer now directly owns 127,767 shares in the company, valued at $39,367,568.04. This trade represents a 17.19% decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders sold 43,751 shares of company stock worth $13,603,991. 0.70% of the stock is owned by corporate insiders.

The Cigna Group Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.